期刊文献+

小剂量阿替普酶对老年急性次大面积肺栓塞的疗效 被引量:7

Effects of lowdose alteplase on acute submassive pulmonary embolism in senile patients
下载PDF
导出
摘要 目的 研究小剂量阿替普酶对老年急性次大面积肺栓塞的疗效和安全性。方法 选择2013年2月-2015年12月在我院诊治的老年急性次大面积肺栓塞患者80例,随机分为两组,各40例。对照组给予华法林和低分子肝素治疗;观察组在此基础上,静脉泵入小剂量(50 mg)阿替普酶,两组均治疗2 w后,比较两组治疗前和治疗后的疗效及动脉血气和右心功能的变化。结果 观察组的治疗总有效明显高于对照组(P〈0.05);与治疗前相比,治疗后两组的氧分压、二氧化碳分压、肺泡动脉氧分压差、D-二聚体、肌钙蛋白和脑钠肽均得到了明显改善(P〈0.05),且观察组的改善程度更明显(P〈0.05);治疗后两组的肺动脉压、右室直径和三尖瓣反流压差均得到了明显改善(P〈0.05),且观察组的改善程度更明显(P〈0.05)。结论 小剂量阿替普酶对老年急性次大面积肺栓塞有较好的疗效,能明显改善动脉血气和右心功能,且不良反应少,安全有效。 Objective To study the effects and safety of lowdose alteplase on acute submassive pulmonary embolism in senile patients. Methods A total of 80 senile patients with acute submassive pulmonary embolism admitted to our hospital from February 2013 to December 2015 were selected and randomly divided into two groups (n = 40, respectively). The control group was treated with warfarin and low molecular heparin; the observation group was additionally treated with lowdose (50 mg) alteplase by intravenous pump; the two groups were treated for two weeks. The efficacy and changes in arterial blood gases and right heart function before and after the treatment were compared, Results The overall response rate (ORR) in the observation group was higher than that in the control group (P 〈 0.05); the arterial blood gases, partial pressure of carbon dioxide, alveolar-arterial oxygen tension difference, D-dimer, troponin and brain natriuretic peptide (BNP) after the treatment were significantly improved (P 〈 0.05), and those in the observation group improved more obviously (P 〈 0.05); the pulmonary arterial pressure, right ventricular diameter and tricuspid regurgitation differential pressure were significantly improved (P 〈 0.05), and the improvement in the observation group was more obvious (P 〈 0.05). Conclusion Lowdose alteplase is effective for acute submassive pulmonary embolism in senile patients, can improve arterial blood gases and right ventricular function, and is safe and effective, causing few adverse reactions.
作者 房莉颖 吴林
出处 《西南国防医药》 CAS 2016年第10期1147-1149,共3页 Medical Journal of National Defending Forces in Southwest China
关键词 急性次大面积肺栓塞 阿替普酶 疗效 安全性 acute submassive pulmonary embolism alteplase effects safety
  • 相关文献

参考文献15

  • 1徐轶俊.D-二聚体测定联合临床评分对急性肺栓塞的诊断价值[J].西南国防医药,2012,22(5):503-505. 被引量:5
  • 2A John S. Thrombolysis for acute submassive pulmonary embolism: CON viewpoint[J]. Thorax, 2014, 69(2):105-107.
  • 3任学良,张吉廷.阿替普酶溶栓治疗ST段抬高型心肌梗死的临床评价[J].西南国防医药,2014,24(8):843-845. 被引量:12
  • 4Miles Fisher MD FRCP Consultant Physician. Alteplase [J]. Practical Diabetes, 2015, 32(9):353-354.
  • 5急性肺血栓栓塞症诊断治疗中国专家共识[J].中华内科杂志,2010,49(1):74-81. 被引量:403
  • 6Ha N, Wan KW. A case of successful thrombolysis in pulmonary embolism with tenecteplase during peripartum period [J]. Acta Cardiologica Sinica, 2011, 27(1):52-55.
  • 7. Stein PD, Dalen JE, Matta F. Underuse of vena cava filters in unstable patients with acute pulmonary embolism [J]. American Journal of Medicine, 2014, 127(1):6.
  • 8Fanikos J, Rao A, Seger AC, et al. Hospital costs of acute pulmonary embolism [J]. American Journal of Medicine, 2013, 126(2):127-132.
  • 9Avgerinos ED, Chaer RA. Catheter-directed interventions for acute pulmonary embolism [J]. Journal of Vascular Surgery, 2015, 61(2):559-565.
  • 10Daley M J, Ishaq L. Clinical controversies in thrombolytic therapy for the management of acute pulmonary embolism [J]. Pharmacotherapy, 2012, 32(2):158-172.

二级参考文献63

  • 1荆志成,邓可武.急性肺动脉血栓栓塞症的溶栓治疗[J].中华医学杂志,2004,84(22):1932-1934. 被引量:20
  • 2方怡,王鸿利.D-二聚体不同检测方法在深静脉血栓和肺栓塞诊断中的选择及其意义[J].诊断学理论与实践,2005,4(5):420-422. 被引量:8
  • 3邹治鹏,何建国,程显声,赵彦芬,陈白屏,高莹,熊长明,倪新海,荆志诚.230例急性肺动脉血栓栓塞症患者对症治疗、抗凝治疗和溶栓治疗的住院转归[J].中国循环杂志,2006,21(3):219-221. 被引量:27
  • 4Yalamanchili K, Fleisher AG, Lehrman SG, et al. Open pulmonary embolectomy for treatnlent of major pulmonary embolism. Ann Thorae Surg, 2004,77:819-823.
  • 5Hann CL, Streiff MB. The role of vena caval filters in the management of venous thromboembolism. Blood Rev, 2005, 19 : 179-202.
  • 6PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d' Embolie Pulmonaire par Interruption Cave) randomized study. Circulation, 2005,112:416-422.
  • 7Karmy-Jones R, Jurkovich GJ, Velmahos GC, et al. Practice patterns and outcomes of retrievable vena cava filters in trauma patients : an AAST multicenter study. J Trauma, 2007,62 : 17-24.
  • 8Barral FG. Vena cava filters: why, when, what and how? J Cardiovasc Surg (Torino) , 2008,49:35-49.
  • 9Meyer G, Sors H, Charbonnier B, et al. Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism : a European nmlticenter double-blind trial. The European Cooperative Study Group for Pulmonary Embolism. J Am Coll Cardiol, 1992, 19:239-245.
  • 10Dalla-Volta S, Palla A, Santolicandro A, et al. PALMS 2: aheplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J Am Coll Cardiol, 1992, 20:520-526.

共引文献417

同被引文献51

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部